The Department of Justice is investigating implant maker Inspire Medical Systems for its marketing, promotion and reimbursement practices, the company disclosed to investors Monday. Inspire, one of ...

During its fourth-quarter earnings call this week, Inspire Medical disclosed that it has become the subject of a civil probe ...

Inspire Medical shares dipped — but have since mostly recovered — following news of a government investigation following Q4 ...

An implant for sleep apnea is one of the few CPAP alternatives. This article compares hypoglossal nerve stimulation and ...

Inspire Medical Systems (NYSE:INSP), known for its innovative devices that use neurostimulation to treat sleep apnea, ...

CEO Tim Herbert told investors the company received a civil investigative demand from the Department of Justice in January ...

Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2024 results topping the market’s revenue ...

Inspire Medical Systems said it is cooperating with U.S. Justice Department probe of allegations into allegations of false claims related to its Inspire system apnea implant. Shares fall 5.5% to $ ...

Inspire expects full-year earnings to be $2.10 to $2.20 per share, with revenue in the range of $940 million to $955 million. This story was generated by Automated Insights ( ...

A wearable medical device that tests for the breathing disorder obstructive sleep apnea has been recommended for use in the NHS by the National Institute for Health and Care Excellence (NICE).